Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

626
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
626
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

246
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
246
Dementia01:30

Dementia

155
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
155
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

212
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
212
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

189
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
189
Introduction to Cognitive Psychology01:20

Introduction to Cognitive Psychology

587
Cognitive psychology is the field of psychology dedicated to examining how people think. It attempts to explain how and why we think the way we do by studying the interactions among human thinking, emotion, creativity, language, and problem-solving, as well as other cognitive processes. Cognitive psychology studies how information is processed and manipulated in remembering, thinking, and knowing.
This field emerged in the mid-20th century, following a period dominated by behaviorism, which...
587

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RDoC-informed explainable AI as a paradigm for multilevel Alzheimer's disease diagnosis and progression prediction: a systematic review.

Brain informatics·2026
Same author

Autism Data Classification Using AI Algorithms with Rules: Focused Review.

Bioengineering (Basel, Switzerland)·2025
Same author

Assessing Autistic Traits in Toddlers Using a Data-Driven Approach with DSM-5 Mapping.

Bioengineering (Basel, Switzerland)·2023
Same author

Autism screening: an unsupervised machine learning approach.

Health information science and systems·2022
Same author

A new classification system for autism based on machine learning of artificial intelligence.

Technology and health care : official journal of the European Society for Engineering and Medicine·2021
Same author

Forecasting Covid-19: SARMA-ARCH approach.

Health and technology·2021
Same journal

Correction: Haddock et al. <i>Imagine the Possibilities Pain Coalition</i> and Opioid Marketing to Veterans: Lessons for Military and Veterans Healthcare. <i>Healthcare</i> 2025, <i>13</i>, 434.

Healthcare (Basel, Switzerland)·2026
Same journal

Macro Responsibility in the Microvascular World: Nurse Experiences in Flap Care, a Phenomenological Study.

Healthcare (Basel, Switzerland)·2026
Same journal

Agreement Between Standing Eight-Point Multifrequency Bioelectrical Impedance Analysis and Dual-Energy X-Ray Absorptiometry for Body Composition Assessment in Apparently Healthy Greek Adults.

Healthcare (Basel, Switzerland)·2026
Same journal

'It's Not About the Food'-Understanding the Lived Experience of Patients Who Developed Hospital-Acquired Malnutrition (HAM) and That of Their Carers.

Healthcare (Basel, Switzerland)·2026
Same journal

Unveiling the Humanizing and Therapeutic Values of Live Music in Healthcare Settings: A Scoping Review.

Healthcare (Basel, Switzerland)·2026
Same journal

Respiratory Rehabilitation and Decannulation in Adults with Prolonged Mechanical Ventilation After Tracheostomy: A Narrative Review.

Healthcare (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Aug 23, 2025

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.3K

Examining Cognitive Factors for Alzheimer's Disease Progression Using Computational Intelligence.

Fadi Thabtah1, Swan Ong2, David Peebles3

  • 1ASDTests, Auckland 0610, New Zealand.

Healthcare (Basel, Switzerland)
|October 27, 2022
PubMed
Summary
This summary is machine-generated.

Predicting Alzheimer's disease (AD) progression is challenging. This study identified key memory and learning items from the ADAS-Cog-13 test, using machine learning, to better forecast AD advancement.

Keywords:
Alzheimer’s Disease (AD)classificationclinical informaticscognitive informaticsdementiamachine learningneuropsychological assessments

More Related Videos

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K

Related Experiment Videos

Last Updated: Aug 23, 2025

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.3K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K

Area of Science:

  • Neurology
  • Artificial Intelligence
  • Cognitive Science

Background:

  • Alzheimer's disease (AD) progression prediction is complex due to numerous patient features.
  • While diagnosis using pathological markers is common, predicting AD advancement via cognitive elements, especially with AI, is less explored.

Purpose of the Study:

  • To evaluate Alzheimer's Disease Assessment Scale-Cognitive 13 (ADAS-Cog-13) items to identify key cognitive factors influencing AD progression.
  • To apply machine learning and feature selection techniques for predicting AD advancement using cognitive data.

Main Methods:

  • A methodology combining machine learning and feature selection was developed.
  • The approach was tested on data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) repository, focusing on ADAS-Cog-13 cognitive items.
  • Ten-fold cross-validation and various classification/feature selection techniques were employed.

Main Results:

  • The decision tree algorithm yielded the best classification models for predicting AD progression using cognitive items.
  • Key predictors of AD advancement identified were memory and learning features: word recall, delayed word recall, and word recognition.
  • Using the C4.5 algorithm with these three cognitive items (excluding demographics) resulted in 82.90% accuracy, 87.60% sensitivity, and 78.20% specificity.

Conclusions:

  • Memory and learning components of the ADAS-Cog-13 test are crucial for predicting Alzheimer's disease progression.
  • Machine learning, particularly decision tree algorithms, can effectively identify cognitive markers for AD advancement.
  • The findings highlight the potential of specific cognitive tests in forecasting disease trajectory, aiding in early intervention strategies.